Common Osteoporosis Drug Shows Promise in Preventing Spinal Disc Decay

Researchers have discovered that an existing osteoporosis medication can successfully block mineral buildup and spinal fusion in genetic models of disc disease. This breakthrough opens up hopeful new pathways for treating chronic back pain using already-approved treatments.